Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.
Source link
Trending
- My father left my mother for another woman. He wants us to start including her. Do we need to? | Australian lifestyle
- Fire danger looms in the West with forecasts of lightning and wind
- Federal firefighters will be encouraged to wear N95 respirators in major policy reversal
- ‘Smaller doses of exercise are a miracle cure’: 14 expert tips to protect your joints | Life and style
- Cold feet: could putting your socks in the fridge help you through the heatwave? | Sleep
- Deadly heat wave grips Europe with red alerts and scorching records
- My eight-year-old was refused a UK passport | Consumer affairs
- The one change that worked: I saw a woman lift 100kg and decided: ‘I want to do that!’ | Life and style
F.D.A. Faces Upset Over Denials of New Drugs
MOST. JESMIN AKTER
Hi , I am MOST JESMIN AKTER . I am Journalist , I am News Reporter of The MoorningTimes Online News Portal
Add A Comment
